Serotonin 5-HT 1A receptors have been implicated in disorders of the central nervous system
and, therefore, are being studied by PET. Efforts are under way to improve in vivo stability …

Introduction Serotonin 5‐HT 1A receptors have been investigated in various CNS disorders,
including epilepsy, mood disorders, and neurodegeneration. [ 18 F]Mefway (N‐{2‐[4‐(2′‐…

We have investigated the opioid receptor (OR) agonist (20R)-4,5-α-epoxy-6-(2- 18 F-fluoroethoxy)-3-hydroxy-α,17-dimethyl-α-(2-phenyleth-1-yl)-6,14-ethenomorphinan-7-methanol
( 18 …

We have developed 18 F‐trans‐Mefway ( 18 F‐Mefway) for positron emission tomography (PET)
imaging studies of serotonin 5‐HT 1A receptors which are implicated in various brain …

553 Objectives Serotonin 5-HT 1A receptors, implicated in CNS disorders, have been
studied with 18 F-trans-Mefway ( 18 F-Mefway) in rodent and nonhuman primate studies. …

1151 Objectives: Changes in serotonin levels in the brain have proved difficult to measure
using PET radiotracers. Competition of endogenous serotonin (fenfluramine-induced …

392 Objectives: Previous work in humans (Kepe, 2005) has shown a 27% hippocampus (HP)
decrease in serotonin 5HT1A receptors in Alzheimer’s disease (AD) using 18F-MPPF. In …

1571 Objectives Serotonin 5HT1A receptors have been investigated in various CNS disorders,
including depression, epilepsy and Alzheimer’s disease. F-Mefway is a new PET imaging …

566 Objectives: 2-[ 18 F]Fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine, 18F-Nifene, is a new
tracer for the α4β2 nicotinic acetylcholine receptors, with faster binding profile in monkey …

Abstract Development of β‐amyloid plaques and neurofibrillary tangles is the hallmark of
Alzheimer's disease (AD) and progressively affects the overall functioning of the brain. …